Clinical Trial Update: The SetPoint System Safety & Performance Post-Approval Study

View source ↗

Summary

A post-approval study update evaluating the safety and performance of the SetPoint System for rheumatoid arthritis, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SetPoint System

Snippet

Sponsor: SetPoint Medical Corporation | Conditions: Rheumatoid Arthritis | Status: NOT_YET_RECRUITING